We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02883556
Brief Title: Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin (CARSKIN)

First Submitted : August 25, 2016
First Submitted that Met QC Criteria : August 29, 2016
First Posted : August 30, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 12, 2021
Last Update Posted : January 13, 2021